Thyroid hormones modify uterine contractility
Endocrinology & Metabolic Syndrome

Endocrinology & Metabolic Syndrome
Open Access

ISSN: 2161-1017

+44 20 3868 9735

Thyroid hormones modify uterine contractility

World Congress on Endocrinology

August 26-28, 2013 DoubleTree by Hilton, Raleigh, NC, USA

Stephanie Corriveau

Scientific Tracks Abstracts: Endocrinol Metab Synd

Abstract :

To date, no study has evaluated whether uterine contractility is modified by hypothyroidism or T 4 treatment. This study analyzes the physiological role of Levothyroxine (T 4 ) and Triiodothyronine (T 3 ) on uterine contractions. Three approaches were used to assess our objectives. Human model . Uterine biopsies were obtained from consenting female patients undergoing elective caesarean under T 4 treatment compared to control patients (N=26). Animal model . To induce hypothyroidism, Sprague- Dawley rats (N=18) followed an iodine deficient diet in absence or in presence of high doses of T 4 (100 ng/kg/day). Isometric tension measurements were performed in vitro on myometrium tissues in isolated organ baths to evaluate the contractile activities using various pharmacological tools. Epidemiological approach . With the aim of extending our in vitro observations, an institutional database was screened to perform a retrospective analysis of pregnancy outcomes on a cohort of 8638 women. On uterine strips from women treated for hypothyroidism, we observed phasic contractions of larger amplitude (+ 77%), with a prolonged duration at 90% relaxation (+ 138%) and reduced frequency (- 55%) as compared to the values from the control group. In the animal model, we demonstrated that hypothyroidism significantly decreases contractile duration, and increase the contractile frequency while high doses of T 4 increases duration and decreases frequency. These results mimic the pattern of abnormal contractions observed in T 4 -treated pregnant women. Upon epidemiological review, the C-section rate was two-fold higher in this group. Thus, a better management of patients is required during pregnancy to reduce the C-section rate in this group.

Biography :

Stephanie Corriveau is a Ph.D. student from Universit de Sherbrooke (Qubec, Canada). Her work focuses on the prevention of preterm labor and more specifically, on the inhibition of myometrial contractile activity. She has already published 5 articles in international journals, among which an original observation in the Am J. of Physiol. Endocrinology and metabolism . She is a recipient of Ph.D. bursaries from both FRQS (Fond de Recherche du Qubec-Sant) and Rx & D Health Research Foundation. She is the recipient of several awards from the Foundation of Stars, Club de Recherches Cliniques du Qubec and the Universit de Sherbrooke Faculty of Medicine and Health Sciences.